Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy.
Saved in:
| Title: | Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy. |
|---|---|
| Authors: | Gillmore JD; University College London, National Amyloidosis Centre, Royal Free Hospital, London., Gane E; University of Auckland, Auckland, New Zealand., Täubel J; Richmond Pharmacology, London., Pilebro B; Umeå University, Umeå, Sweden., Echaniz-Laguna A; Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France., Kao J; Auckland City Hospital, Auckland, New Zealand., Litchy W; Mayo Clinic, Rochester, MN., Shahda S; Intellia Therapeutics, Cambridge, MA., Haagensen A; Intellia Therapeutics, Cambridge, MA., Walsh L; Intellia Therapeutics, Cambridge, MA., Smith D; Intellia Therapeutics, Cambridge, MA., Kachadourian J; Intellia Therapeutics, Cambridge, MA., Ward JH; Intellia Therapeutics, Cambridge, MA., Lebwohl D; Intellia Therapeutics, Cambridge, MA., Zhu P; Intellia Therapeutics, Cambridge, MA., Xu Y; Intellia Therapeutics, Cambridge, MA., Leung A; Intellia Therapeutics, Cambridge, MA., Sonderfan A; Intellia Therapeutics, Cambridge, MA., Gutstein DE; Regeneron Pharmaceuticals, Tarrytown, NY., Manvelian G; Regeneron Pharmaceuticals, Tarrytown, NY., Adams D; Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France. |
| Source: | The New England journal of medicine [N Engl J Med] 2025 Oct 09; Vol. 393 (14), pp. 1375-1386. Date of Electronic Publication: 2025 Sep 25. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Multicenter Study |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41002250 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gillmore+JD%22">Gillmore JD</searchLink>; University College London, National Amyloidosis Centre, Royal Free Hospital, London.<br /><searchLink fieldCode="AU" term="%22Gane+E%22">Gane E</searchLink>; University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Täubel+J%22">Täubel J</searchLink>; Richmond Pharmacology, London.<br /><searchLink fieldCode="AU" term="%22Pilebro+B%22">Pilebro B</searchLink>; Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Echaniz-Laguna+A%22">Echaniz-Laguna A</searchLink>; Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22Kao+J%22">Kao J</searchLink>; Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Litchy+W%22">Litchy W</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Shahda+S%22">Shahda S</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Haagensen+A%22">Haagensen A</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Walsh+L%22">Walsh L</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Kachadourian+J%22">Kachadourian J</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Ward+JH%22">Ward JH</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Lebwohl+D%22">Lebwohl D</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Zhu+P%22">Zhu P</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Leung+A%22">Leung A</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Sonderfan+A%22">Sonderfan A</searchLink>; Intellia Therapeutics, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Gutstein+DE%22">Gutstein DE</searchLink>; Regeneron Pharmaceuticals, Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Manvelian+G%22">Manvelian G</searchLink>; Regeneron Pharmaceuticals, Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Adams+D%22">Adams D</searchLink>; Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220255562%22">The New England journal of medicine</searchLink> [N Engl J Med] 2025 Oct 09; Vol. 393 (14), pp. 1375-1386. <i>Date of Electronic Publication: </i>2025 Sep 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Massachusetts+Medical+Society%22">Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0255562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4406 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200284793%22">00284793 </searchLink><i>NLM ISO Abbreviation: </i>N Engl J Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41002250 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1056/NEJMoa2510209 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1375 Titles: – TitleFull: Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gillmore JD – PersonEntity: Name: NameFull: Gane E – PersonEntity: Name: NameFull: Täubel J – PersonEntity: Name: NameFull: Pilebro B – PersonEntity: Name: NameFull: Echaniz-Laguna A – PersonEntity: Name: NameFull: Kao J – PersonEntity: Name: NameFull: Litchy W – PersonEntity: Name: NameFull: Shahda S – PersonEntity: Name: NameFull: Haagensen A – PersonEntity: Name: NameFull: Walsh L – PersonEntity: Name: NameFull: Smith D – PersonEntity: Name: NameFull: Kachadourian J – PersonEntity: Name: NameFull: Ward JH – PersonEntity: Name: NameFull: Lebwohl D – PersonEntity: Name: NameFull: Zhu P – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Leung A – PersonEntity: Name: NameFull: Sonderfan A – PersonEntity: Name: NameFull: Gutstein DE – PersonEntity: Name: NameFull: Manvelian G – PersonEntity: Name: NameFull: Adams D IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 10 Text: 2025 Oct 09 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1533-4406 Numbering: – Type: volume Value: 393 – Type: issue Value: 14 Titles: – TitleFull: The New England journal of medicine Type: main |
| ResultId | 1 |